Back to search

Article

Measuring the health-related quality of life in HIV patients with integrase strand transfer inhibitor-based regimens in China

2024-07-18

Abstract excerpt

<title>Abstract</title> <p> Background With bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF), and dolutegravir/lamivudine (DTG/3TC) included in the national drug reimbursement list, the integrase strand transfer inhibitor (INSTI)-based regimens could be afforded and used by more patients. Majority of previous health-related quality of life (HRQoL) studies were conducted before INSTI-based regimens r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f1a9dbff-326b-57f8-9be8-c86361bd86f6
DOI
10.21203/rs.3.rs-4635838/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Measuring the health-related quality of life in HIV patients with integrase strand transfer inhibitor-based regimens in ChinaDOI 10.21203/rs.3.rs-4635838/v1
Select a neighboring publication to make it the new centre.